Skip to main content
. 2020 Feb 14;2020:3852420. doi: 10.1155/2020/3852420

Table 2.

Overall survival in sarcoma patients undergoing ablation.

Variable Univariate Multivariate
Median (months) p Model coefficient 95% CI Hazard ratio p
Sex 0.36
 Male 49.6
 Female 53.1
Age 0.92
 >50 years 52.4
 <50years 55.9
Tumour size 0.033 0.54 0.87–3.38 1.72 0.1159
 ≤3 cm 53.1
 >3 cm 31.6
Index tumour grade 0.19
 High 53.1
 Low Not reached
Histologic subtype 0.17
 Leiomyosarcoma 55.9
 GIST 78.1
 Liposarcoma Not reached
 Chondrosarcoma 24.3
 Other 46.9
Failed previous chemotherapy 0.027 −0.56 0.31–1.06 0.57 0.0749
 No 62.6
 Yes 33.2
Disease-free interval 0.87
 <12 months 52.4
 >12 months 55.7

Log-rank tests of no differences among categories vs. any differences among categories.